Developing vaccines to prevent HIV-1 infection
Official title: NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
Funded at Advanced Bioscience Laboratories, INC. · NIH-11041800 · Data updated 2026-11-12
This study is working on new vaccines to help prevent HIV-1, the virus that causes AIDS, so that people can have better options for staying healthy and avoiding the virus in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | September 1, 2018 |
| Project end | June 27, 2027 |
| Funding year | 2024 |
| Award (this year) | $60,889 |
| NIH project number | 272201700010I-P00003-27200011-1 |
| Project ID | NIH-11041800 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at high risk for HIV-1 infection or those interested in preventive measures against HIV.
✕Less likely to help
Patients who are already living with HIV-1 may not receive direct benefits from this research focused on prevention.
What this research studies
This research focuses on creating and testing new vaccines to prevent HIV-1, the virus that causes AIDS. It involves developing various types of vaccines, including DNA plasmids and viral vectors, and conducting preclinical tests to ensure their safety and effectiveness. The research aims to streamline the process of bringing these vaccines to human clinical trials by managing all aspects of development, production, and regulatory documentation. Patients may benefit from advancements in HIV prevention through improved vaccine options.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the risk of HIV-1 infection.
How similar studies have gone: Previous research has shown promise in developing HIV vaccines, but this approach aims to enhance and expedite the process, making it a potentially novel advancement.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Vancott, Thomas — Advanced Bioscience Laboratories, INC.
- Study coordinator: Vancott, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.